As shown in Figure 5A,B, immunostaining with antibody directed against proliferation marker Ki-67 revealed a highly significant increase in the rate of BC cell proliferation in the MDA-MB-231 tumors growing under experimental ME conditions, in agreement with the greater tumor size detected in mice implanted with the endotoxin-infusing pumps (Figure 4A). Here, MKI67 is linked to breast cancer.